DAFNA Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-20,000
| Closed | -$210K | – | 92 |
|
2019
Q3 | $210K | Buy |
20,000
+17,000
| +567% | +$179K | 0.08% | 82 |
|
2019
Q2 | $51K | Hold |
3,000
| – | – | 0.02% | 86 |
|
2019
Q1 | $101K | Hold |
3,000
| – | – | 0.04% | 77 |
|
2018
Q4 | $88K | Hold |
3,000
| – | – | 0.04% | 80 |
|
2018
Q3 | $185K | Hold |
3,000
| – | – | 0.08% | 73 |
|
2018
Q2 | $221K | Buy |
+3,000
| New | +$221K | 0.1% | 72 |
|
2018
Q1 | – | Sell |
-2,000
| Closed | -$168K | – | 82 |
|
2017
Q4 | $168K | Hold |
2,000
| – | – | 0.09% | 70 |
|
2017
Q3 | $231K | Hold |
2,000
| – | – | 0.14% | 63 |
|
2017
Q2 | $234K | Hold |
2,000
| – | – | 0.17% | 65 |
|
2017
Q1 | $247K | Buy |
+2,000
| New | +$247K | 0.21% | 64 |
|